| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/15/2006 | EP1634498A2 Exo-S-mecamylamine formulation |
| 03/15/2006 | EP1634081A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 03/15/2006 | EP1633756A2 A2a adenosine receptor antagonists |
| 03/15/2006 | EP1633752A1 Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof |
| 03/15/2006 | EP1633751A1 Carboline and betacarboline derivatives for use as hdac enzyme inhibitors |
| 03/15/2006 | EP1633742A1 Indole derivative in the form of serotonin reabsorbing inhibitors |
| 03/15/2006 | EP1633741A1 Indole derivatives as serotonin reuptake inhibitors |
| 03/15/2006 | EP1633735A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 03/15/2006 | EP1633733A1 Cannabinoid derivatives, methods of making, and use thereof |
| 03/15/2006 | EP1633720A1 Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases |
| 03/15/2006 | EP1633440A1 Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles |
| 03/15/2006 | EP1633402A2 Pharmaceutical composition |
| 03/15/2006 | EP1633400A2 Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines |
| 03/15/2006 | EP1633363A1 Pyridinyl acetonitriles |
| 03/15/2006 | EP1633361A1 Anxiety treatments with ziprasidone |
| 03/15/2006 | EP1633360A1 Treatment of psychotic and depressive disorders |
| 03/15/2006 | EP1633358A1 Pharmaceutical compositions of varenicline |
| 03/15/2006 | EP1633356A1 Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity |
| 03/15/2006 | EP1633355A1 Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor |
| 03/15/2006 | EP1633346A1 Pyrrolidin-1, 2- dicarboxylic acid- 1- (4- ethinyl- phenyl) - amid]- 2- (phenyl)- amid] derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis |
| 03/15/2006 | EP1633343A1 3-aminomethyl-pyrrolidines as n-type calcium channel blockers |
| 03/15/2006 | EP1633338A1 Combination of the analeptic modafinil and an antidepressant for the treatment of depression |
| 03/15/2006 | EP1633334A2 A method of promoting sleep using topical administration of vasoactive agents |
| 03/15/2006 | EP1633316A2 Antibodies that immunospecifically bind to trail receptors |
| 03/15/2006 | EP1513834B1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 03/15/2006 | EP1509530B1 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 03/15/2006 | EP1461040B1 Succinic acid salts of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9 ]-hexadeca-2(11),3,5,7,9,-pentaene and pharmaceutical compositions thereof |
| 03/15/2006 | EP1448566B1 Chemokine receptor antagonists and methods of use thereof |
| 03/15/2006 | EP1444206B1 Substituted benzo[b]azepin-2-one compounds as analgesics |
| 03/15/2006 | EP1408962B1 Substituted isoindoles and the use thereof |
| 03/15/2006 | EP1383498B1 Crf receptor antagonists |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1309589B1 Urea compounds and methods of uses |
| 03/15/2006 | EP1289992B1 New crystalline form of a triazolo(4,5-d)pyrimidine compound |
| 03/15/2006 | EP1196172B1 (S,S)-Reboxetine for treating chronic pain |
| 03/15/2006 | EP1129078B1 Indazole derivatives with 5-ht2 receptor activity |
| 03/15/2006 | EP1068315B1 Therapeutic agent for ngf |
| 03/15/2006 | EP0929554B1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 03/15/2006 | EP0826035B1 Isolating and culturing schwann cells |
| 03/15/2006 | CN1747947A A process for preparing duloxetine and intermediates for use therein |
| 03/15/2006 | CN1747942A Heterocyclic compounds useful as nurr-1 activators |
| 03/15/2006 | CN1747747A Aprotinin and analogs as carriers across the blood-brain barrier |
| 03/15/2006 | CN1747740A Analgesic composition |
| 03/15/2006 | CN1747735A Use of s-10 hydroxy-10, 11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders |
| 03/15/2006 | CN1747719A Topical compositions and methods for treating pain |
| 03/15/2006 | CN1745817A Medicine for treating cerebral arteriosclerosis |
| 03/15/2006 | CN1745793A Compound Chinese medicine for treating epilepsy |
| 03/15/2006 | CN1745789A Head invigorating capsule and its preparation thereof |
| 03/15/2006 | CN1745783A Medicine against depressive disorders and preparation thereof |
| 03/15/2006 | CN1245417C Prodrugs of dipeptidyl peptidase IV inhibitors |
| 03/15/2006 | CN1245405C Piperazine derivatives |
| 03/15/2006 | CN1245391C Pyrimidine, Triazine and pyrazine derivatives as glutamate receptors |
| 03/15/2006 | CN1245386C 1,2-dihydropyridine compounds, process for preparation of same and use thereof |
| 03/15/2006 | CN1245382C 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 03/15/2006 | CN1245376C Substituted 2-dialkylamino alkylbiphenyl derivatives |
| 03/15/2006 | CN1245216C Stabilized liquid polypeptide-containing. pharmaceutical compositions |
| 03/15/2006 | CN1245193C Plant leaven with hot and fragrant smell of propylene sulfide and its preparation and use |
| 03/15/2006 | CN1245189C Composition for strengthening body resistance and restoring and function, strengthening spleen and kidney, relieving mental stress and promoting blood circulation to remove blood stasis |
| 03/15/2006 | CN1245184C Insomnia treating traditional Chinese medicine preparation and its preparing process |
| 03/15/2006 | CN1245169C Memory and perception improving pure natural composite preparation and its preparing process |
| 03/15/2006 | CN1245167C Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles |
| 03/15/2006 | CN1245162C Synergistic precursor medicine compound for treating Alzheimer disease |
| 03/14/2006 | US7012146 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders |
| 03/14/2006 | US7012099 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
| 03/14/2006 | US7012096 Comprising a weak organic acid such as acetic acid, vinegar, and/or citric acid dispersed within a carrier, at acidic pH, for treating burns; provides local analgesia |
| 03/14/2006 | US7012089 Administering to a patient suffering from psychological disoders a (1,4)diazocino(7,7,1-hi)inodle derivative as 5HT2c agonist or partial agonist |
| 03/14/2006 | US7012087 Anticancer agents |
| 03/14/2006 | US7012085 As antipsychotics in therapy of schizophrenia, depression, bipolar disorders, cognition deficits, Parkinson disease, drug abuse, attention deficit hyperactivity disorders, glaucoma, diabetes and erectile dysfunction |
| 03/14/2006 | US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders |
| 03/14/2006 | US7012071 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 03/14/2006 | US7012069 For therapy of heart disease and stroke, Alzheimer's disease, and an inflammatory disorder |
| 03/14/2006 | US7011973 recombinant DNA molecules comprising regulatory sequences of an intron of the Vascular Endothelial Growth Factor receptor-2 gene or of a gene homologous to the Flk-1 gene, being capable of conferring expression of a heterologous DNA sequence |
| 03/14/2006 | US7011951 Apoptosis-associated gene |
| 03/14/2006 | US7011854 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| 03/14/2006 | US7011828 Regeneration cells of nervous system |
| 03/14/2006 | US7011820 Delivery of compounds for the treatment of Parkinsons through an inhalation route |
| 03/14/2006 | US7011813 Cocaine receptor binding ligands |
| 03/14/2006 | CA2521953C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 03/14/2006 | CA2380810C Pyridomorphinans and use thereof |
| 03/14/2006 | CA2376091C Ethanesulfonyl-piperidine derivatives |
| 03/14/2006 | CA2359363C 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/14/2006 | CA2308867C New substitute pyridine or piperidine compounds, their preparation process and the pharmaceutical compositions containing these compounds |
| 03/14/2006 | CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 03/14/2006 | CA2241014C Morphine derivatives with analgesic activity |
| 03/14/2006 | CA2127166C Sustained release morphine compositions and a method of preparation |
| 03/09/2006 | WO2006026533A2 Methods of treatment of amyloidosis using ethanol cyclicamine derivatives aspartyl protease inhibitors |
| 03/09/2006 | WO2006025517A1 Sodium channel inhibitor |
| 03/09/2006 | WO2006025471A1 Piperidine derivative or pharmaceutically acceptable salt thereof |
| 03/09/2006 | WO2006025267A1 Remedy for sleep disorders using lowering in per2 protein level as the action mechanism |
| 03/09/2006 | WO2006025247A1 Mitochondria activators |
| 03/09/2006 | WO2006025057A1 Use of il-6 in vascular complications |
| 03/09/2006 | WO2006024947A2 Methods and materials relating to enhanced production of dopamine neurons |
| 03/09/2006 | WO2006024932A1 2-amino-quinazoline derivatives useful as inhibitors of b-secretase (bace) |
| 03/09/2006 | WO2006024627A2 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 03/09/2006 | WO2006024236A1 Medicine having analgesic effects |
| 03/09/2006 | WO2006024121A1 Use of n-phenylpiperazine derivatives and pharmaceutical compositions containing them |
| 03/09/2006 | WO2005097751A3 Non-imidazole heterocyclic compounds as histamine h3-receptor ligands |
| 03/09/2006 | WO2005087238A3 Method for stimulating the immune, inflammatory or neuroprotective response |
| 03/09/2006 | WO2005014572A8 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 03/09/2006 | US20060053498 Full-length human cdnas encoding potentially secreted proteins |